Simplex Trading’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,846
| Closed | -$96.4K | – | 9947 |
|
|
2025
Q4 | $96.4K | Buy |
+2,846
| New | +$88.4K | ﹤0.01% | 5035 |
|
|
2025
Q3 | – | Sell |
-197
| Closed | -$2.58K | – | 9872 |
|
|
2025
Q2 | $1K | Buy |
197
+165
| +516% | +$1.26K | ﹤0.01% | 8405 |
|
|
2025
Q1 | $0 | Buy |
+32
| New | +$315 | ﹤0.01% | 9435 |
|
|
2024
Q4 | – | Sell |
-402
| Closed | -$5.11K | – | 9423 |
|
|
2024
Q3 | $6K | Buy |
402
+28
| +7% | +$566 | ﹤0.01% | 7547 |
|
|
2024
Q2 | $9K | Sell |
374
-6,142
| -94% | -$284K | ﹤0.01% | 7515 |
|
|
2024
Q1 | $468K | Buy |
+6,516
| New | +$906K | ﹤0.01% | 3926 |
|
|
2023
Q4 | – | Sell |
-84
| Closed | -$10.4K | – | 9630 |
|
|
2023
Q3 | $11K | Buy |
84
+79
| +1,580% | +$12.9K | ﹤0.01% | 7124 |
|
|
2023
Q2 | $0 | Sell |
5
-235
| -98% | -$36.6K | ﹤0.01% | 9756 |
|
|
2023
Q1 | $35K | Buy |
+240
| New | +$48.5K | ﹤0.01% | 6333 |
|
|
2022
Q1 | – | Sell |
-536
| Closed | -$101K | – | 11216 |
|
|
2021
Q4 | $157K | Sell |
536
-5,437
| -91% | -$1.45M | ﹤0.01% | 5530 |
|
|
2021
Q3 | $1.47M | Buy |
5,973
+387
| +7% | +$102K | ﹤0.01% | 2568 |
|
|
2021
Q2 | $1.42M | Buy |
+5,586
| New | +$1.04M | ﹤0.01% | 2638 |
|
|
2021
Q1 | – | Sell |
-163
| Closed | -$26.9K | – | 9814 |
|
|
2020
Q4 | $25K | Buy |
+163
| New | +$35.4K | ﹤0.01% | 6829 |
|
Simplex Trading's RAPT Position: Q1 2026 in Review
Simplex Trading sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 2,846 shares — an estimated $96.4K sold.
Simplex Trading first reported a position in RAPT in Q4 2020 and held it in 13 quarters. The position peaked at $1.47M in Q3 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- Simplex Trading reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 2,846 RAPT Therapeutics shares in Q1 2026, an estimated $96.4K.
- Simplex Trading first reported a position in RAPT Therapeutics in Q4 2020 and held it in 13 quarters.
- Simplex Trading's RAPT Therapeutics position peaked at $1.47M in Q3 2021.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.